Pathological changes in PSVD: current view and future directions – Paris PSVD Meeting

Value of the Information & Strength of the Argument

The presentation provides significant value by presenting original research that addresses key gaps in PSVD diagnosis. The argumentation is solid, based on systematic studies with clear methodologies, including morphometric analysis and multi-reader validation. The speakers effectively demonstrate the need for quantitative thresholds and standardized terminology, and they provide evidence for specific criteria. The logical progression from identifying challenges to proposing solutions is well-structured.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with the presentation of original data from well-designed studies. The sources cited include previous consensus papers and studies by recognized experts, such as Jim Crawford and Isabel Field. The title accurately reflects the content, and the presentation is consistent with the stated topic. The work is part of a COST action and involves collaboration among multiple pathologists, enhancing its credibility.

The title accurately reflects the content, covering current pathological features and future directions in PSVD.

8/10

Presentation of original research by experts in the field, with detailed methodology and data, but limited peer-review context and no external verification.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 01:00Introduction to PSVD and the role of the pathologist.
• 03:00Discussion of challenges: biopsy length, terminology, specificity, thresholds.
• 05:00Evidence for 15 mm biopsy length to rule out cirrhosis.
• 07:00Standardization of terminology and use of 2019 publication.
• 09:00Morphometric analysis of normal liver to derive thresholds.
• 12:00Multi-reader study to assess reproducibility and association with PSVD.
• 15:00Identification of portal vein stenosis as a major feature with high correlation.
• 18:00Definition of major and minor criteria for PSVD diagnosis.
• 21:00Validation of criteria in a larger cohort and creation of histological atlas.
• 24:00Future directions: validation in PSVD without portal hypertension and pediatric cases.

• Consensus paper on PSVD — Referenced for biopsy length recommendation.
• Position paper by liver pathologists — Proposed standardized terminology.
• Publication by Jim Crawford on normal portal tract — Described normal portal tract anatomy.
• Morphometric analysis by Isabel Field's group — Evaluated portal tract and vein areas.
• COST action working group on histology — Led by Christine Sempoux, aimed to define lesions and terminology.

• De Gottardi et al. (2019) - Porto-sinusoidal vascular disease: proposal of a new classification — Referenced for terminology and classification.